Editorial: Imagine a future nearly free of COVID
For a moment’s respite from pandemic news that can seem unrelentingly bad, cast your mind into the future — say, to November 2021.A world in suspended animation has awakened at last. The pandemic has subsided. New cases of COVID-19 are a rarity.In the United States, the death toll is just under half a million. As awful as that number is, it might have been worse.Masks are still a common sight, but they no longer incite fisticuffs among strangers.Schools have done away with their hybrid instruction models and have embraced in-class learning with a new enthusiasm. Students who were never able to...
Star Tribune (Minneapolis)
Editorial: Restore faith in COVID-19 vaccines
Pfizer officials announced on Oct. 16 that the pharmaceutical giant won’t be ready to apply for FDA approval of its COVID-19 vaccine until the third week of November.That means there will be no miracle Election Day vaccine — which should assuage fears that this potentially lifesaving development might be prematurely rushed past scientific protocols for political ends.A credible vaccine is needed, especially with coronavirus cases once again trending upward across the country.However, to prevent the spread of the potentially deadly virus, any vaccine must not only be safe and effective, it must...
The Seattle Times
Thinking of stealing money from the feds? First, meet Jeff Grant, an ex-con who committed loan fraud
Thinking about stealing the government loan money you received in pandemic help?Before you do, listen to Jeff Grant’s story.After his opioid addiction, his theft of U.S. loan funds, and a federal prison sentence, Grant’s life as a lawyer and business professional was over.But according to him, his new life was just beginning. And for small business owners feeling desperate — enough to steal — he’s created a safe place to talk anonymously and seek guidance.Now clean and sober, remarried and out of prison, Jeff Grant, 64, co-founded the online organization Progressive Prison Ministries, what cou...
The Philadelphia Inquirer
Commentary: In the race for a COVID-19 vaccine, how do we balance risk and safety?
The great race for a COVID-19 vaccine has more than 130 medicines in development, with 40 being tested on humans, of which 10 are in large, phase 3 trials. The U.S. Government has invested about $11 billion in Operation Warp Speed, making advance purchases from Moderna, Johnson & Johnson, Pfizer/BioNTech, Sanofi/GlaxoSmithKline, Novavax and AstraZeneca — betting that at least some will be soon approved by regulators as “safe and effective” vaccines.No matter your Twitter feed, “vaccines have been one of the greatest public health tools to prevent disease,” as The New York Times explained in Ja...
Gov. Cuomo talks VAP as he urges feds to prepare for COVID vaccine distribution
NEW YORK — Giving Cardi B a run for her money, Gov. Andrew Cuomo on Sunday gushed about the state’s forthcoming program to dole out a coronavirus vaccine — or VAP for short.He called on the feds to provide basic answers about distribution so states can start to plan for the eagerly-awaited remedy.“This is a larger operational undertaking, I would argue, than anything we have done during COVID to date,” Cuomo said at a Manhattan press conference. “We need the federal government to be a competent partner with this state and with every state.”With the feds overseeing development of the vaccine — ...
New York Daily News
Pfizer says coronavirus vaccine won't be ready until Thanksgiving — at the earliest
Pfizer Inc., one of the many pharmaceutical companies racing to develop a coronavirus vaccine, said it hopes to have a treatment authorized for emergency use by the end of the year.CEO Albert Bourla in an open letter published Friday revealed that while scientists are working quickly to develop a vaccine, that it would not be ready by Election Day — a claim that has been repeatedly made by President Donald Trump. He added that the earliest the company would seek authorization from the Food and Drug Administration would be the third week of November.Pfizer expects to have preliminary numbers by...
New York Daily News
What we know and don't know about the pauses in COVID-19 trials
Johnson & Johnson announced Monday that it has halted its massive COVID-19 vaccine trial after a participant became ill.Less than 24 hours later, Eli Lilly paused a study of a COVID-19 antibody treatment for the same reason.What does this all mean?We reached out to two San Diego scientists, Dr. Davey Smith of the University of California, San Diego and Dennis Burton of Scripps Research, for the answer. Both researchers are deeply involved in the search for new COVID-19 treatments and intimately familiar with clinical trials.As with most things related to the coronavirus, there are more questio...
The San Diego Union-Tribune
Trump said he was 'immune' to the coronavirus. Here's what the science says
Twitter on Sunday slapped a warning on President Donald Trump’s tweet that he can’t get or give the coronavirus, saying the post violated rules “about spreading misleading and potentially harmful information related to COVID-19.”Is there any evidence that the president is immune? And even if he is, could he still be infectious? Let’s look at what is known — and unknowable.It means your immune system produces proteins, called antibodies, against a specific disease. Natural immunity can be acquired either by getting the disease or through vaccination, according to the U.S. Centers for Disease Co...
The Philadelphia Inquirer
Nation and world news briefs
Abbott gets emergency FDA approval for antibody test that detects recent COVID-19 infectionsCHICAGO — Abbott’s latest antibody test — meant to show whether a person has recently had COVID-19 — has gained emergency use authorization from the U.S. Food and Drug Administration.The blood test detects a type of antibody, called IgM, that’s present after a person has been recently infected with COVID-19, Abbott said in a news release.It’s the second antibody test made by Illinois-based Abbott to gain emergency use authorization, in which the FDA allows the use of unapproved medical products to diagn...
Tribune News Service
Abbott gets emergency FDA approval for antibody test that detects recent COVID-19 infections
CHICAGO — Abbott’s latest antibody test — meant to show whether a person has recently had COVID-19 — has gained emergency use authorization from the U.S. Food and Drug Administration.The blood test detects a type of antibody, called IgM, that’s present after a person has been recently infected with COVID-19, Abbott said in a news release.It’s the second antibody test made by Illinois-based Abbott to gain emergency use authorization, in which the FDA allows the use of unapproved medical products to diagnose, treat, or prevent serious or life-threatening diseases when certain criteria are met.Ab...